Clarity in every comparison.Key takeaways
- Match the product, DIN and lot—not just the ingredient.
- A dose-display issue is not the same as the separate impurity recall.
- Follow the current official notice and healthcare professional advice.
What the notice identifies
Health Canada’s notice lists Apo-Semaglutide 2 mg/pen, DIN 02568020, lot 7000599A. It describes a dose-display issue affecting that lot; this should not be interpreted as a recall of every semaglutide product.
Where to check
Read the official notice and compare the product and lot information. Health Canada advises speaking with a healthcare provider before discontinuing the affected product or about health concerns. This brief does not replace the official instructions.
How to check a package without guessing
Keep the carton and device available when contacting the pharmacy. Read the product name, DIN and lot number exactly as printed. If a number is hard to find, ask the pharmacist where it appears rather than substituting a prescription number or expiry date.
A photograph may help a pharmacist identify the packaging, but avoid posting a prescription label publicly. It can contain your name, pharmacy record number and other personal information.
What to ask the dispensing pharmacy
Ask whether the package matches the affected lot and what action follows from the current notice. Describe a display concern in your own words; do not try to correct a device or estimate an alternative setting using an online article.
Record the notice link and the advice you receive. If you are unsure about treatment while the issue is resolved, ask your healthcare professional. This article does not provide instructions to stop, restart, replace or change medication.
Frequently asked questions
Does this notice mean all semaglutide is recalled?
No. Check the specific product and lot scope in the official notice. Other semaglutide notices may concern different products or issues.
Should I change a device setting myself?
Do not use this article to adjust a device. Ask the pharmacist or healthcare professional and follow the official product instructions.
Sources & further reading
View source notes for this article →
The date above identifies the source announcement or article, not the publication date of this RxTally explanation.